International Society for the Study of Women's Sexual Health

Outcomes & Objectives

Target Audience

Potential attendees of the meeting include (but or not limited to) physicians, residents, students, nurse practitioners, physical therapists and sex therapists.

Outcomes

  • Providers gain awareness and are educated about important differences between genders in the susceptibility/response to disease, as well as differences in response to treatment, optimizing current therapeutic choices in an array of clinical settings
  • Providers gain awareness and are educated about human desire and mate selction from the perspective of evolutionary psychology.
  • Providers will be educated about the latest research on genetic mechanisms that regulate sexual arousal and desire.
  • A thorough understanding of compulsive sexual behavior, treatment options and current standards of care will lead to improvement in knowledge base and ability to inform and treat patients.
  • HCPs will be educated on the most recent peer-reviewed clinical studies in selected areas.  This includes a current understanding of sexuality in post-menopausal women, as well as treatments for women with lifelong vaginismus.
  • A thorough understanding of addictive sexual behavior, treatment options and current standards of care will lead to improvement in knowledge base and ability to inform and treat patients.
  • Practitioners will become more aware of novel or alternative therapies that can be beneficial to certain patients with sexual dysfunctions that are currently considered to be difficult to manage.
  • Increased diagnosis and proper treatment of the specific vulvar dermatoses, including medical and surgical treatment.
  • By reviewing the evidence-based data regarding the efficacy, risks, and benefits of both hormonal and nonhormonal treatment options for GSM, healthcare providers can better educate their patients and facilitate the decision-making process when it comes to managing this common condition.
  • Providers will offer the full range of hormone options to appropriate patients with menopausal symptoms who desire treatment.
  • Fair-balanced, scientific education about HPV-related disorders and vaccinations will be taught and translated into clinical practice. 
  • Participants should leave this session with an increased comfort in the process of initiating discussion of sexual issues with patients, and responding to patients’ questions/concerns.
  • Participants will be exposed to an integrated mindfulness based model of addressing sexual pain and penetration anxiety which will improve their knowledge and sexual pain disorders competence in addressing comopnents of pain and anxiety.
  • More accurate diagnosis of primary headache and more effective treatments which take into account multiple factors which contribute to the frequency, severity and duration of headache in women.
  • Practitioners will gain a basic level of competence in using Twitter and blogs to develop a public presence, adapted to practice setting and desired goals.
  • Providers will be educated about the prevalence and classification of sexual disorders and improve their detection and evaluation of these problems in an array of clinical settings. 
  • Clinicians will use the motivational interviewing technique Ask-Tell-Ask, which assesses the patient’s prior knowledge/experience as well as the patient’s reactions to a recommended treatment strategy, when counseling patients about sexual problems. 
  • Fair-balanced, scientific education about correct physical examination assessment including general sexual pain will be taught and will help the clinician translate this knowledge into clinical practice. 
  • Improvement in competence of providers resulting in better patient (and partner) understanding the specific dysfunction, potentially better treatment compliance and finally better patient outcomes.
  • The practitioner will be able to determine the different causes of painful sexual intercourse and therefore better able to treat it appropriately.
  • Fair-balanced, scientific education about relationship of hormones to vestibulodynia and testing for neuro-proliferative vestibulodynia as part of diagnosis and treatment paradigm will be taught for translation into clinical practice. 
  • Fair-balanced, scientific education about vaginal lubricants, moisturizers and vaginal/vulvar creams for use in women with sexual dysfunction will be taught as well as translated for use in clinical practice, along with behavioral therapy.
  • A thorough review of the data, risks and benefits in different patient circumstances, presentations of the choices and options available to patients and key discussion points will lead to improvement in knowledge base and ability to inform and treat patients.
  • Providers learn how to counsel patients about the benefits and risks associated with off label testosterone use and to advise patients in selecting various off label testosterone treatments available.
  • By reviewing the evidence-based data regarding the efficacy, risks, and benefits of both hormonal and non-hormonal treatment options for GSM, healthcare providers can better educate their patients and facilitate the decision-making process when it comes to managing this common condition.
  • Patient outcome is improved as shown by FSFI increasing and SDS-R decreasing.
  • Providers will fully evaluate women with sexual problems and psychiatric co-morbidity and implement evidence-based treatment strategies that address the complex relationship between these clinical conditions. 
  • Sexual health providers will understand truths of sexual medicine in order to incorporate within individual practices and best care for clients with sexual complaints 

Objectives

  • Understand the molecular and genetic basis of gender differences.
  • Understand how evolutionary psychological theory can shed light on human behavior in terms of desire and mate selection. 
  • Understand what epigenetic mechanisms are and how they impact sexual arousal and desire.
  • Describe the nature of compulsive sexual behavior, its etiology and treatment options and to remove unnecessary hurdles to access care.
  • Understand the major findings of the most recent clinical studies on sexuality in post-menopausal women and treatment of women with lifelong genital pain.
  • Describe the nature of addictive sexual behavior, its etiology and treatment options and to remove unnecessary hurdles to access care.
  • Understand novel therapeutic alternatives and incorporate these into their overall strategy in caring for patients with sexual dysfunctions that are related to sexual abuse, anti-depressant use or genital pain.
  • Recognize lichen sclerosus, lichen planus, lichen simplex chronicus; Learn the proper treatment for these vulvar dermatoses.
  • Recognize the clinical manifestations of Genitourinary Syndrome of Menopause; Apply evidence-based treatment options, both hormonal and nonhormonal, to the management of GSM.
  • Describe efficacy of oral, transdermal and local hormone therapy. Understand safety of oral, transdermal and local hormone therapy.
  • (1) Participants will be able to utilize the PLISSIT Model to guide their decisions regarding levels of intervention with patients exhibiting sexual concerns; and (2) Participants will have specific suggestions regarding the initiation of discussions of sexual issues patients.
  • Identify pain science principles and apply them to typical sexual pain presentations: Apply a multidimensional mindfulness based approach that will address pain and anxiety reduction while consideration the clients culture, context, and goal orientation.
  • Evaluate the primary complaint of headache within the medical, social and behavioral spheres to arrive at appropriate treatment strategies.
  • Demonstrate how social media can be used for professional education/continuous professional development, networking, clinical trials promotion, and patient education through authoritative health messaging; Identify institutional and individual best practices.
  • (1) Understand the broad epidemiology, prevalence, classification systems and models for female sexual disorders in clinical practice; (2) Summarize current nomenclature as well as new terminology in the area of female sexual dysfunction. 
  • (1) Implement the patient-centered, collaborative motivational interviewing technique Ask-Tell-Ask in sexual problem counseling for female sexual dysfunctions; (2) Apply principles of patient interviewing to the area of sexual health.
  • (1) Describe the detailed physical examination with focus on the genito pelvic region; (2) Discuss possible sources of sexual pain related to skin, musculoskeletal, infective, pharmacologic and genitourinary factors; (3) Cite possible first line treatment opportunities for pelvic floor dysfunction focusing on simple solutions for hypertonus.
  • (1) Describe the various diagnostic tests needed to properly diagnose a women with sexual dysfunction; (2) Apply results of diagnostic testing to help determine etiology of sexual function.
  • (1) Know the three most common causes of dyspareunia; (2) Learn the appropriate aspects of the medical history and physical examination that determine the cause of the dyspareunia; (3) Characterize HPV and other possible vulvar diseases that may be seen through the course of examining women presenting with dyspareunia and therefore can be successfully treated; (4) Learn to recognize which subset of women will benefit from the surgical treatment of dyspareunia; (5)  Learn the proper techniques for vulvar vestibulectomy.
  • (1) Characterize subset of women who will benefit from the surgical treatment of dyspareunia; (2) Analyze blood tests to understand the relevance of values to vestibular health and vestibulodynia.
  • (1) Describe the specific action and indications for use of vaginal lubricants, moisturizers and vulvar creams in the treatment of sexual dysfunction; (2) Describe potential irritants and caustic additives that may hinder sexual comfort; (3) Apply behavioral therapy principles in clinical practice.
  • Apply relevant data and appropriate individual choices to the education of patients in order to guide them through the process of HT decision making; Analyze the major differences in available HT choices to help individualize the treatment and enhance the benefits while decreasing the risks for the menopausal patient.
  • (1) Identify the benefits and risks associated with off label testosterone use for Hypoactive Sexual Desire Disorder (distressing low sexual desire); (2) Compare and contrast the off label use of various FDA-approved male products in women and compounded testosterone treatment options.
  • (1) Recognize the clinical manifestations of Genitourinary Syndrome of Menopause; (2) Apply evidence-based treatment options, both hormonal and non-hormonal, to the management of GSM; (3)  Describe innovative treatments for GSM.
  • (1) Cite rational and logical use of off-label treatments affecting central excitatory neurotransmitters; (2) Cite rational and logical use of off-label treatments affecting central inhibitory neurotransmitters.
  • (1) Discuss the relationship between common psychiatric disorders in women, particularly depression, and female sexual dysfunctions; (2) Describe an evidenced-based approach to the appropriate use of psychopharmacological agents in this clinical context.
  • (1) Differentiate between truth/fiction with regard to prevalence, etiologies and treatment options for sexual issues. (2) Appraise value of sex educator’s information and knowledge base; or Associate myths in sex education with their genesis.
  • Associate links between HPV infection and malignancies.
    • Describe the colposcopic, vulvoscopic and oropharyngeal presentations of HPV related disease and understand appropriate follow up and management.
    • Describe risk-reducing strategies whereby the patient may modify his or her behavior to reduce risk.
    • Cite the benefits of HPV vaccination.

Save The Date


ISSWSH Annual Meeting 2018

  February 8-11, 2018  77 days left
  Hilton San Diego on Mission Bay
San Diego, CA, USA

Latest Tweets

Fifty Shades of Belgian Gray: The Prevalence of BDSM-Related Fantasies and Activities in the General Population https://t.co/AbLlU5ZTLt ISSWSH
RT @SexHlthMatters: Girls with #vaginalagenesis are born without a fully formed vagina. Treatment may involve dilation and surgery, but man… ISSWSH
RT @SexHlthMatters: After orgasm, some people sleep soundly or bond with their partner. Others get severe #headaches or have sneezing fits.… ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville MN, 55306

USA

Phone: +1 (952) 683 9025

Fax: +1 (612) 808 0491
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.